Evidence map›Paper›PMID 35585637›Full record

ArticleMolecular autism2022

Resting state EEG power spectrum and functional connectivity in autism: a cross-sectional analysis.

Pilar Garcés, Sarah Baumeister, Luke Mason, Christopher H Chatham, Stefan Holiga, Juergen Dukart, Emily J H Jones, Tobias Banaschewski, Simon Baron-Cohen, Sven Bölte and 17 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Molecular autism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06817746 (Fostering Infant Responsivity and Reciprocity - Support to Thrive. A Multisite Randomized Control Trial of a Preemptive Telehealth Intervention for Infants With Early Signs of Autism Spectrum Disorders), which is not on this map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06817746 narecruitingnot on this mapstarted 2024, after this paper: background citation

Fostering Infant Responsivity and Reciprocity - Support to Thrive. A Multisite Randomized Control Trial of a Preemptive Telehealth Intervention for Infants With Early Signs of Autism Spectrum Disorders

TypeinterventionalSponsorIRCCS Fondazione Stella MarisRan2024 to 2027Enrolled132ConditionsAutism Spectrum Disorder (ASD)ArmsFIRRST, Parent Education
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 13 institutions in 8 countries.

Pilar GarcésRoche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland. pilar.garces@roche.com.ORCID 0000-0003-4989-0123
Sarah BaumeisterDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Luke MasonDepartment of Psychological Sciences, Centre for Brain and Cognitive Development, Birkbeck, University of London, London, UK.
Christopher H ChathamRoche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Stefan HoligaRoche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Juergen DukartInstitute of Neuroscience and Medicine, Brain and Behaviour (INM-7), Research Centre Jülich, Jülich, Germany.
Emily J H JonesDepartment of Psychological Sciences, Centre for Brain and Cognitive Development, Birkbeck, University of London, London, UK.
Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Simon Baron-CohenDepartment of Psychiatry, Autism Research Centre, University of Cambridge, Cambridge, UK.
Sven BölteDepartment of Women's and Children's Health, Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Karolinska Institutet and Child and Adolescent Psychiatry, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Jan K BuitelaarDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
Sarah DurstonBrain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
Bob OranjeBrain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
Antonio M PersicoInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital, University of Messina, Messina, Italy.
Christian F BeckmannDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
Thomas BougeronHuman Genetics and Cognitive Functions, Institut Pasteur, UMR3571 CNRS, Université de Paris, Paris, France.
Flavio Dell'AcquaInstitute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
Christine EckerInstitute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
Carolin MoessnangDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Tony CharmanInstitute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
Julian TillmannRoche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Declan G M MurphyInstitute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
Mark JohnsonDepartment of Psychological Sciences, Centre for Brain and Cognitive Development, Birkbeck, University of London, London, UK.
Eva LothInstitute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
Daniel BrandeisDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Joerg F HippRoche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
EU-AIMS LEAP group authorship
Roche (Switzerland) · CHKing's College London · GBBirkbeck, University of London · GBHeidelberg University · DERadboud University Nijmegen · NLUniversity Medical Center Utrecht · NLGoethe University Frankfurt · DEUniversity of Messina · ITUniversity of Zurich · CHCentre National de la Recherche Scientifique · FRCurtin University · AUHeinrich Heine University Düsseldorf · DEUniversity of Cambridge · GB

Funding

Medical Research Council MR/T003057/1
6 · The paper itself

Abstract

backgroundUnderstanding the development of the neuronal circuitry underlying autism spectrum disorder (ASD) is critical to shed light into its etiology and for the development of treatment options. Resting state EEG provides a window into spontaneous local and long-range neuronal synchronization and has been investigated in many ASD studies, but results are inconsistent. Unbiased investigation in large and comprehensive samples focusing on replicability is needed.

methodsWe quantified resting state EEG alpha peak metrics, power spectrum (PS, 2-32 Hz) and functional connectivity (FC) in 411 children, adolescents and adults (n = 212 ASD, n = 199 neurotypicals [NT], all with IQ > 75). We performed analyses in source-space using individual head models derived from the participants' MRIs. We tested for differences in mean and variance between the ASD and NT groups for both PS and FC using linear mixed effects models accounting for age, sex, IQ and site effects. Then, we used machine learning to assess whether a multivariate combination of EEG features could better separate ASD and NT participants. All analyses were embedded within a train-validation approach (70%-30% split).

resultsIn the training dataset, we found an interaction between age and group for the reactivity to eye opening (p = .042 uncorrected), and a significant but weak multivariate ASD vs. NT classification performance for PS and FC (sensitivity 0.52-0.62, specificity 0.59-0.73). None of these findings replicated significantly in the validation dataset, although the effect size in the validation dataset overlapped with the prediction interval from the training dataset. LIMITATIONS: The statistical power to detect weak effects-of the magnitude of those found in the training dataset-in the validation dataset is small, and we cannot fully conclude on the reproducibility of the training dataset's effects.

conclusionsThis suggests that PS and FC values in ASD and NT have a strong overlap, and that differences between both groups (in both mean and variance) have, at best, a small effect size. Larger studies would be needed to investigate and replicate such potential effects.

Indexed as

Autism Spectrum DisorderAutistic DisorderAdolescentAdultBrainBrain MappingChildCross-Sectional StudiesElectroencephalographyHumansMagnetic Resonance ImagingReproducibility of ResultsAutism spectrum disorderEEGFunctional connectivityPower spectrumResting state

Identifiers

PMID35585637
PMCPMC9118870
OpenAlexW4280622035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.